With the recognition that h u m a n infection with Coxsackie (C) viruses m a y be a relatively common occurrence, it is important to establish methods for determining the immunological reactions of this group of agents. Published work from other laboratories as well as our own has indicated that these agents produce serological responses similar to those of other viruses. Thus tests for neutralizing (1-5) and complement-fixing antibodies (4-8) have already been adapted to these newly discovered agents, but the details of the mechanics of these tests and their reliability have not as yet been described. It is the purpose of this series of three papers to describe in some detail immunological reactions of the C viruses. The first and present paper deals with the neutralization test, the second (9) with the complement fixation test, and the third (10) with crossprotection tests.
per ml. was added to the diluent, so that the 10 .2 virus suspension contained I000 units of penicillin and 5 mg. of streptomycin per rnl.
Serum.--Human sera were usually frozen at -20°C. soon after collection; although a few samples were kept at 2°C. without any observed deleterious effect on the antibody. These were obtained from normal people, or as paired samples from patients.
Hyperimmune sera were prepared in 2-to 4-week-old albino mice by intraperitoneal inoculation with I0 per cent suspension of infected murine muscle-bone (or in some instances infected brain). The recommended course was 6 inoculations consisting of 0.I ml. each twice weekly for 3 weeks. Mice were bled by cardiac puncture 8 to 10 days later. Booster inoculations were given about every 4 or 5 weeks followed by a serum harvest in 8 to 10 days. A similar course was used for preparing serum in hamsters except that infected baby hamster tissue was used as the vaccine.
Monkeys belonging to the following species were used, and all responded with satisfactory antibody development when subjected to the indicated course of vaccination: rhesus (Macaca mulatta), cynomolgus (Macaca irus, Macaca eynomolgus), green (Cercopithecus aethiops sabaeus), and sooty mangabey (Cercocebus fuliginosus). However, following oral administration of virus, eynomolgus monkeys responded preferentially (11) . With these animals a series of 3 to 4 weekly inoculations (each being 2 to 5 ml. of 10 -1 infected murine tissues) were performed dividing each inoculum intraperitoneally, intramuscularly, and intracutaneously. Animals were given booster inoculations at intervals of 4 to 6 weeks. Serum was collected 8 to 10 days after vaccination. All animal sera were stored frozen.
Method of Carrying Out the Test.--In all instances, serum dilutions (made with saline or
1 per cent horse serum as diluent) were added to the test tubes (I0 X 75 ram.) before the addition of virus. The volumes used were 0.2 ml. of each reagent, which were well shaken following their mixture. Incubation was varied as indicated, although the standard test now in use employs a period of 1 hour at room temperature.
Test Mice.--Newborn animals in groups of 8 to 1 mother were used. These animals were usually less than 24 hours and almost never more than 48 hours old. Pregnant albino mice (and on occasion "chocolate" mice) were obtained from four different dealers, and no apparent difference in susceptibility of their young was noticed. The young from several mothers were often mixed and redistributed at random with 8 mice put in the care of each mother. Following inoculation of the serum-virus mixtures, mice were observed daily for 10 to 14 days. Virulent strains of the Texas type have short incubation periods and such tests can be terminated safely by the 10th day. Mice which died within 2 days of the inoculation and mice which disappeared (cannibalism) were not included in the tabulations. Groups of mice in which all died without signs of paralysis being observed in any, were considered unsatisfactory and tests performed with such groups were repeated. Mice were inoculated with 0.02 ml. either intraperitoneally or subcutaneously (between the shoulders where the skin is loose). It is felt that the latter route is more satisfactory from the standpoint of less leakage of the inoculum.
Calculation of Results.--The
Reed-Muench method was used to calculate all 50 per cent end-points, and was used in computing the neutralization index when varying doses of virus were employed. The neutralization index equals the difference in titer between that in the presence of control normal horse serum and the test serum.
The results of serum neutralization tests with varying dilutions of serum against a fixed dose of virus (about 100 IDs0) were generally, for a single dilution'of serum, either all-or-none neutralization. Serum titers are therefore given as the greatest serum dilution tested which neutralized the virus.
EXPERIMENTAL
Stability of the Virus.--Earfier results in which four strains (Texas-I, High Point, Conn.-5, Ohio-l) in 50 per cent glycerol were found to survive a trip to Sweden at "room" temperature gave some indication of the stability of the C viruses. To compare the stability under different temperatures the following experiments were carried out.
Brains and muscle were harvested from infected mice (Conn.-5, High Point, and Texas-I strains). Portions from each mouse were cut into small pieces and placed in 50 per cent glycerol. The remainder was ground with water to make a 10 per cent suspension. Part of this was added to an equal volume of undiluted normal monkey serum, and part was frozen without addition of serum at --20°C. Tubes containing the infected tissue in glycerol and in serum were stored at 2°C. and some at 25°C. and aliquots removed for titration at intervals ~hown in Table I .
The virus was found to be stable and retain its titer for several months when frozen at -20°C. When a virus-rich tissue such as muscle was used, virus was still present when stored at 25°C. for 70 days, although the titer decreased by several logs. In glycerol at 2 ° , the virus, particularly in fragments of infected muscle, decreased only slightly in titer when stored for over 1 year. For work with viruses of known titer, it is now our practice to make up a large batch of virus suspension as 10 per cent suspension of carcass, distribute it in 1 ml. amounts, and freeze these tubes at --20°C. until needed.
Effect of Time, Temperature, and Diluent on Virus Titration End-Points.-To determine the effect of time, temperature, and diluent on the end-point of a virus titration, the High Point strain (9th mouse passage) was diluted both in saline, and in normal, inactivated 10 per cent horse serum to give the following dilutions: 10 -e, 10 --7, and l0 s. Aliquots of these dilutions were kept (a) at room temperature for 1 hour; (b) at 37°C. for 2 hours; (c) at room temperature for 1 hour, followed by incubation at 4°C. for 20 hours; and (d) at room temperature for 1 hour, followed by incubation at -20°C. for 96 hours. The results shown in Table II indicate that the virus is stable in dilute suspensions (10 -6 and 10 -7) under all the conditions tested. The use of either saline or 10 per cent normal horse serum gave comparable virus titers. Similar results have been obtained with several strains. The effect of time and temperature on serum neutralization end-points was investigated by incubating aliquots of various dilutions of 3 immune sera with their homologous viruses (100 ID60 doses of each were used) under the following conditions: (a) at room temperature for 10 minutes; (b) at room temperature for 1 hour; (c) at 37°C. for 2 hours; 4d) at room temperature for 1 hour, followed by storage at --20°C. for 4 days; and (e) at room temperature for 1 hour followed by storage at -20°C. for 14 days.
From the results of Table III , it is seen that human serum (NC-77B) heated at 56°C. for 30 minutes, and unheated chimpanzee serum (Becky October 4, 1949) gave the same serum end-points (the maximum dilution to give complete protection) when incubated at room temperature for 10 minutes as when incubated at room temperature for 1 hour, followed by incubation at -20°C. for 4 days. The Easton-20 acute and convalescent serum end-points were the same when aliquots were incubated at room temperature for I hour, and at room temperature for I hour followed by incubation at -20°C. for 14 days. Thus, the serum neutralization end-points were the same, when the same serum was compared under varying conditions of incubation. A similar pattern was obtained with other strains, in which the incubation period was allowed to vary between 25 minutes and 3 hours at room temperature. These experiments illustrate the fact that neutralized virus mixtures can be stored and tested at a later date to yield the same results as freshly mixed serum and virus. At the time of carrying out a neutralization test, an aliquot of each virus-serum mixture may be frozen away to allow for the replacement of those groups of mice which fail to survive for 2 days after inoculation, or which turn out to be unsatisfactory for some other reason.
When the neutralization index is obtained by mixing varying dilutions of virus with an undiluted serum, the virus in the mixture remains neutralized when frozen at -20°C. for several days. In the presence of normal serum, the virus titer is not affected by the freezing. A typical experiment yielding these results, which are shown in Table IV , follows:--The ~-IF 1943 strain (2nd mouse passage) was serially diluted and aliquots mixed with an equal volume of 1WHF immune serum, and as controls, additional samples were mixed with normal inactivated horse serum. Aliquots of the mixtures were incubated at room temperature for 1 hour; and at room temperature for 1 hour, followed by incubation at --20°C. for ,5 days. The mixtures with normal horse serum gave the same 50 per cent virus end-point under both of these conditions of incubation (10 -8"I and 10-8'2). Similarly, the 50 per cent n~fUNOLOGICAL REACTIONS OF COXSACKIE VIRUSES. I virus end-point was the same, under these conditions, in the presence of the undiluted immune serum (< 10-2). The difference between the negative logarithms of the 50 per cent virus endpoints obtained in immune and normal serum was > 6.1 when incubated at room temperature for 1 hour, and > 6.2 when incubated at room temperature for 1 hour, followed by incubation at --20°C. for 5 days. Similar results have been obtained on the stability of other strains under these conditions. 
TABLE IV Effect of Time and Temperature on the Neutralimtion Index
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lO"s 717 (7) 8/8 (7) 10 ~ 10 ~ 10 ~ IDa0 of the High Point strain gave a serum titer of 100 when injected by either route. The subcutaneous route of injection gives occasional virus titers 1 log higher than by the intraperitoneal route, particularly with the Ohio strain (Table VI) . In view of this fact, and also because the inoculum is less apt to leak following the latter route of injection, we use as a routine the subcutaneous route for injections, Effect of Complement.--To determine whether complement played a role in the in vitro phase of the neutralization test, the following experiment was conducted.
Convalescent serum obtained from a patient 1 month after an acute illness characterized by fever, weakness, and abdominal pain and by isolation of a Conn.-5 type of C virus was used. Preliminary results using undiluted sera and serial tenfold dilutions showed that serum taken I month before illness contained no detectable antibodies to the Conn.-5 strain, whereas Mter an incubation period of 1 hour at room temperature, the mixtures were tested for infectivity as shown in Table VII .
It can be seen that complement had no effect on the serum neutralization titer, which was found to be 256 in the absence as well as in the presence of complement.
IMM-.YNOLOGICAL REACTIONS OF COXSACKIE VIRUSES. I
Effect of Heat on Neutralizing Antibodies.--To determine whether or not the virus-neutralizing substances present in human serum were heat-labile, titrations of various sera, before and after heating, were carried out against different strains of the virus. First a series of tests were performed in which several posi- Hi.Pt.
Hi.Pt.
Ohio-1
Ohio-I
Ohio-1
Conn. -5 Conn.-5 tire human sera were titrated against 100 IDs0 doses of the High Point and Ohio strains of virus, before and after they were heated at 56°C. for 30 minutes. Non-specific inhibitors to a variety of viral agents have been shown to be destroyed at this temperature (12, 13) . The results shown in Table VIII indicate that the neutralizing antibody to C virus in human sera is stable at 56 ° C. for 30 minutes.
Further experiments were conducted to determine the heat lability of the neutralizing antibody.
For this purpose, convalescent sera were selected from patients from whom C virus had been recovered during their acute illness, using in the neutralization tests a strain of virus related to that isolated from the patient. In addition, a chimpanzee serum was studied, ohmined from an animal following three serial infections with three different immunological types of C virus (Texas-l, Conn.-S, and Ohio-l). The heat stability of the neutralizing antibody to each strain in this serum containing multiple antibodies, as well as in the convalescent human sera, was studied by heating the sera for 30 minutes at the following temperatures: 56 °, 60 °, 65 °, 70 °, 75 °, and 80°C. Then the serum fiter of the unheated serum was compared to that obtained with the heated serum, using 100 IDs0 doses of virus.
The results in Table IX illustrate the stability of the neutralizing antibody to four immunological types of virus. With low titered sera (1:40 or less), the titer was maintained at 56°C.; all detectable antibody was destroyed at temperatures at 70 ° (or less). With sera having titers above 1:120, the antibody was not altered at 65 ° and had to be heated to 75 °, and in two instances (only one is illustrated in the table) in which the serum titers were above 1:400, the serum had to be heated to 80 ° before the antibody was no longer detectable. Texas-1 nl~ 8.C ) ' 10 100 l 1 2
Conn.-5 m7 6.5 >1000 >1000 >3 >3
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Conn.-5 m7 6. Table X , it appears that the neutralization of C virus strains does not give a straight line relationship between serum titer and quantity of virus neutralized. However, as the quantity of virus is increased, the quantity of serum required for neutralization likewise increases, but for a uniform increase in the quantity of virus, the serum titer was not found to decrease in similar uniform fashion, as has been reported for other viruses (14, 15) .
Dissociatiort of the Virus-Antibody
Complex.--To determine whether neutralized mixtures of the virus could be made infective by dilution, as was first shown by Andrewes for the pox viruses (16), the following experiments were performed.
TABLE XI
E~ect of Dilution on Dissociation of Antigen-Antlbody Complex
Texas-I strain plus Texas-I strain plus saline A 10 per cent suspension of carcasses infected with the Texas-1 strain was mixed with an equal amount of undiluted Texas monkey hyperimmune serum and incubated for 1 hour at room temperature. This was designated as 10 -1 , and the mixture was then diluted with saline in a series of tenfold dilutions to 10 -s. Each dilution was injected into infant mice. At the same time, the virus suspension was incubated with saline under the same conditions, diluted, and 10 ~ to 10 -s concentrations of this control injected. Previous experience showed that higher concentrations of the virus were invariably fatal for mice. The results of two duplicate experiments have been combined and are listed in Table XI. Complete protection of the 10 -1 virus was afforded by undiluted serum and the mixture remained non-infective following a tenfold dilution. However, the virus was infective when the mixture was diluted 100, 1000, and 10,000 times designated as 10-3, 10 -4 , and 10 -5 concentrations of virus in the table. At the 10 -6 and 10-7 concentrations, containing 20 and 2 IDs0 doses of virus respectively, and serum concentrations of 10-5 and 10 -e, the virus was again non-infective. It would appear that at this level of virus, traces of antibody were sufficient to neutralize again this small amount of virus, or that two logs of virus had been destroyed. By titrating the virus in the presence of tenfold dilutions of serum such as were present in the diluted mixture, (i.e., 10 °05 infected tissue plus an equal volume of 10 -~ immune serum, 10 -8 infected tissue plus 1000" serum, 1000 7 infected tissue plus 10 --e serum, etc.), it was shown that such traces of serum were incapable of influencing the virus titer. Thus although neutralized virus-serum mixtures may be reactivated by simple dilution, some of the virus is rendered irreversibly non-infective. Further experiments in strain classification in which varying dilutions of virus have been set up against undiluted immune sera are summarized in Table  XIII . We now recognize at least seven different immunological types?
Antibody Devdopment in Relation to Human Disease.--The available evidence suggests that neutralizing antibodies to different strains of C virus develop early in the course of the disease (1, 4) . Further information on the specificity of the neutralizing antibody response has been obtained from an extensive From each patient a virus was isolated during the acute phase of illness which was typed by following the reactions with specific hyperimmune animal sera (see bottom three rows of Table XIV ). The data in Table XIV also show that no patient before his illness had detectable antibodies to the strain subsequently isolated from him or to the prototype strain. But soon after illness, there developed simultaneously antibodies to the strain isolated from the patient and to the prototype strain to which it was related.
The reactions of the sera of the laboratory patients with strains not related to the one iso- lated from each patient are instructive. Only 2 of the 6 patients had an illness due to Texas type infection, yet the other 4 must have had a subclinical infection with this type. The results with the serial samples of blood taken from patient JLM starting several months before his illness emphasize this point: On November 29, 1948, antibodies were absent to both the Conn. and Texas types. By February 21, 1949 , antibodies to the Texas type had appeared in fiter of 1 : 100 and this serum level was maintained in the next 4 bleedings carried out in May, June, and October of that year. The patient became ill (diagnosis compatible with epidemic pleurodynia or myalgia) on May 16 at a time when he had no antibodies to his own strain or to the Conn. prototype. By May 26, such antibodies were present. Concerning antibodies to the Ohio type, 2 patients had such antibodies before they became ill (to a heterolognus type). Three of the remaining 4 persons did not develop Ohio antibodies during the period studied, whereas a fourth, LMK, did--at the time of illness. The LMK strain proved to belong to the Ohio type.
TABLE XV
Family Infection with Two Types of Coxsachie Virus
At the time of JLM's infection with the Conn. type, his family was infected with yet another type. His daughter, Nancy aged 8, was iU with 2 bouts of fever (maximum 103.5°), the first from May 14 to 16 and the second from May 27 to 28. Virus was isolated from fecal samples collected May 21 and June 5. Her strain belonged to a hitherto unknown type, shown by the data in Table XV. Nancy's mother was a healthy carrier of this strain as evidenced by isolation of the virus from her stools collected on June 10. However, unlike Nancy, she did not develop neutralizing antibodies to her own virus, nor to the Conn. type which was the causative agent of her husband's illness. Nancy developed antibodies to her own virus, to her mother's virus, but not to her father's virus. Between May 18 and 26, her father developed antibodies not only to his virus and to the Conn. type to which it was related, but also to the type which infected the other two members of the family. The only reason for interpreting his illness as due to the Conn. type and not to Nancy's type was the isolation of a Conn. type virus during his illness. Actually, strains isolated early in his disease (stools of May 19) and late (throat swab of May 31) were typed and both belonged to the Corm.-5 type.
Duration of Neutralizing Antibodies in Man and Their Occurrence in Normal
Populations.--In order to attempt an answer to this question 3 patients, proven to be infected with C virus by means of virus isolation plus antibody responses (4), were followed for a period of over 2 years. 2 The data of Fig. 1 indicate that neutralizing bodies appear early (by the 5th day of onset), increase rapidly to titers of 1:1250 which are maintained during the period of 1 to 3 months following infection, and may still be present 2 years later, although at lower levels (titer of 1:50 to 1:250). Studies with strains belonging to other types have not been as extensive, but fit into the same pattern. The frequency of the finding of neutralizing antibodies in normal adult human sera and gamma globulin also supports the view that these antibodies persist for long periods.
The largest series in this study is concerned with over 200 children in Winston-Salem~ North Carolina, who were bled in May, 1948, and again 6 months later. During this period, an epidemic of poliomyelitis occurred in the area, having its peak incidence in July. Antibody tests were carried out with the High Point strain, isolated from a sample of urban sewage collected in July of that year from High Point, a small city about 20 miles from WinstonSalem. All sera were inactivated at 56°C. for 30 minutes before use. Serum dilutions were set up against 100 ID60 doses of virus. It was soon discovered that when antibodies were present the serum titer was over 10 and usually about I00. When a serum dilution of 10 was negative, the undiluted serum was usually also negative. Consequently, in Fig. 2 we have plotted the percentage of sera with titers of 10 or over. From the determinations on 20 placental sera, it was found that a high percentage of children start life with antibodies to this C strain. The level falls rapidly to a minimum of 14 per cent positive at the age of 1, and then it quickly rises to reach the adult level of 80 per cent at the age of 7. It is of interest that a sizable number of healthy children who were devoid of antibodies in May developed them by November. The relationship of these antibody levels, and changes in them during the summer, to other antibodies forms the subject of another report (18) .
Neutralizing antibodies to specific types may occur in certain normal populations as shown by the finding in one area that 60 normal sera all contained antibodies to the Texas-1 type but not to the Conn.-5 type. That the latter strain is not localized to the state in which it was isolated in 1948, is suggested by its crossing with a strain isolated in Winston-Salem, North Carolina, and by the finding of antibodies to the Conn. strain in adults in Sweden. Furthermore, gamma globulin collected in different parts of this country and in Denmark has been found to contain antibodies to at least four antigenic types of C virus (Table XVI) .
We are indebted to Dr. Albert B. Sabin for making these scra available to us. Although a single type may predominate in a given area, it has been our experience in three poliomyelitis epidemic areas to find more than one immunological type of virus in the population. This has been true of the epidemics in 1948 in Texas and in North Carolina and in 1949 in East on, Pennsylvania. It is of interest that two antigenic types of virus were isolated from one family. However the exposure of this family was unusual in that one member was actively engaged in laboratory work in the C viruses.
The six infections which occurred in laboratory workers at Yale---as well as the infections reported among British workers--serve as good illustrations of the specificity of the response, each patient responding in a matter of days with antibodies to the strain isolated from his intestines or throat. These experiences serve as an accidental but nonetheless fine example that strains belonging to the Conn.-5, Ohio-l, and Texas-1 types can cause disease in man. To these should be added the Type 2 virus in light of the British work (23) with human volunteers.
SUMMARY
The neutralization test is a reliable and useful procedure for following immunological reactions of the Coxsackie viruses (C virus).
The standard procedure has been an incubation period of 1 hour at room temperature followed by subcutaneous inoculation into newborn mice. However, this time and temperature are not critical, for the virus in neutralized within 10 minutes of mixing with immune serum and remains neutralized for long periods. During the variable incubation periods used, the control virus remained active, even in dilute suspensions.
The neutralization test is not affected by the presence or absence of complement.
Neutralizing antibody is stable at 65°C. for 30 minutes, and immune serum has to be heated to 80°C. for 30 minutes before the antibody is no longer detectable.
As the quantity of virus is increased, the quantity of serum required for neutralization likewise increases, but not in a regular or predictable fashion.
Neutralized mixtures of the virus can be made infective again by simple dilution before inoculation.
The neutralization test is a satisfactory means for typing Coxsackie viruses. At least seven antigenic types have been identified. Similar antigenic types have been found to be scattered over wide areas. Thus the Conn. Further information on the specificity of the neutralizing antibody response has been obtained from a study of the occurrence and development of antibodies in 6 patients who contracted infections with one or another of the C viruses while working with them in the laboratory. From each patient a virus was isolated during the illness. No patient had detectable antibodies to his strain before his illness, but each soon thereafter developed antibodies to his own strain and to the prototype strain to which it was related.
By means of the neutralization test, it has been shown that a family epidemic may include two different immunological types of virus.
Neutralizing antibodies appear at the time of or soon after onset of illness, increase rapidly to titers of about 1:1000 which are maintained during the period of 1 to 3 months following infection, and are still present 2 years later, although at lower levels.
Neutralizing antibodies are present in the normal population. In North Carolina, over 80 per cent of the children have antibodies at birth. The level falls rapidly to a minimum of 14 per cent at the age of 1, and then it quickly rises to reach the adult level at the age of 7. Gamma globulin collected in various parts of the United States between 1944 and 1949 and in Denmark in 1949 neutralizes at least four antigenically different Coxsackie viruses.
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